4.1 Article

Diagnosis and Treatment of Dystonia

Journal

NEUROLOGIC CLINICS
Volume 33, Issue 1, Pages 77-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ncl.2014.09.002

Keywords

Blepharospasm; Botulinum toxin; Cervical dystonia; Deep brain stimulation; Focal hand dystonia; Meige syndrome; Oromandibular dystonia; Spasmodic dysphonia

Funding

  1. National Institutes of Health (NIH)
  2. Ipsen Pharmaceuticals
  3. Merz Pharmaceuticals
  4. Psyadon pharmaceuticals
  5. Atlanta Clinical & Translational Science Institute
  6. Emory University Research Council
  7. Lesch-Nyhan Syndrome Children's Research Foundation
  8. Dystonia Medical Research Foundation
  9. Bachmann-Strauss Dystonia & Parkinson's Foundation
  10. Benign Essential Blepharospasm Research Foundation
  11. NIH from the Office of Rare Diseases Research in the National Center for Advancing Translational Sciences [NS065701]
  12. National Institute of Neurologic Disorders and Stroke

Ask authors/readers for more resources

The dystonias are a group of disorders characterized by excessive involuntary muscle contractions leading to abnormal postures and/or repetitive movements. A careful assessment of the clinical manifestations is helpful for identifying syndromic patterns that focus diagnostic testing on potential causes. If a cause is identified, specific etiology-based treatments may be available. In most cases, a specific cause cannot be identified, and treatments are based on symptoms. Treatment options include counseling, education, oral medications, botulinum toxin injections, and several surgical procedures. A substantial reduction in symptoms and improved quality of life is achieved in most patients by combining these options.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available